Dr. Eric Goosby: The M72 vaccine could be a breakthrough. “It is a moment.”

The CommonHealth

Content provided by CSIS Global Health Policy Center | Center for Strategic and International Studies, CSIS Global Health Policy Center | Center for Strategic, and International Studies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CSIS Global Health Policy Center | Center for Strategic and International Studies, CSIS Global Health Policy Center | Center for Strategic, and International Studies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

1y ago 28:38

MP3•Pagina episodului

Dr. Eric Goosby walks us through the Lancet Commission report on tuberculosis—which he chaired—that was issued immediately prior to the September 22 UN High Level Meeting on TB. The environment for progress remains very tough—shortfalls in political will, prioritization, finances, and investment by industry. But there are recent, promising gains in diagnostics and therapies. And a promising vaccine, M72, is now in advanced trials. That could be a breakthrough in the future. GSK, in partnership with Gates Foundation and Wellcome Trust, are investing $550m in fields trials across Africa and Southeast Asia. What was the significance of the High-Level Meeting? It generated a detailed agenda to which national governments should be held to account. Eric closes with personal reflections on the passing of Senator Dianne Feinstein.

271 episoade

#Fitness #Non-Profit #Business #News #Government #CSIS Global Health Policy Center | Center for Strategic #International Studies